First Wave BioPharma Announces Second Patient Dosed in Phase 2 SPAN Clinical Trial of Enhanced Adrulipase Formulation in Cystic Fibrosis March 10, 2023
Tellurian COO Keith Teague retires and Samik Mukherjee joins as Driftwood Assets President May 16, 2022